IL152554A0 - PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII - Google Patents
PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIIIInfo
- Publication number
- IL152554A0 IL152554A0 IL15255401A IL15255401A IL152554A0 IL 152554 A0 IL152554 A0 IL 152554A0 IL 15255401 A IL15255401 A IL 15255401A IL 15255401 A IL15255401 A IL 15255401A IL 152554 A0 IL152554 A0 IL 152554A0
- Authority
- IL
- Israel
- Prior art keywords
- factor
- pharmaceutical composition
- xiii
- viia
- factor viia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000778 | 2000-05-10 | ||
DKPA200000771 | 2000-05-10 | ||
DKPA200000871 | 2000-06-06 | ||
PCT/DK2001/000322 WO2001085198A1 (en) | 2000-05-10 | 2001-05-10 | tHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIA AND A FACTOR XIII |
Publications (1)
Publication Number | Publication Date |
---|---|
IL152554A0 true IL152554A0 (en) | 2003-05-29 |
Family
ID=27222387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15255401A IL152554A0 (en) | 2000-05-10 | 2001-05-10 | PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII |
Country Status (17)
Country | Link |
---|---|
US (3) | US20030092627A1 (da) |
EP (3) | EP1282438B1 (da) |
JP (2) | JP2004505016A (da) |
CN (1) | CN1304049C (da) |
AT (2) | ATE300953T1 (da) |
AU (3) | AU5822801A (da) |
BR (1) | BR0110659A (da) |
CA (1) | CA2406583A1 (da) |
CZ (1) | CZ20023667A3 (da) |
DE (2) | DE60115422T2 (da) |
DK (1) | DK1282438T3 (da) |
ES (2) | ES2254414T3 (da) |
HU (1) | HUP0301868A3 (da) |
IL (1) | IL152554A0 (da) |
NO (1) | NO20025355L (da) |
PL (1) | PL365042A1 (da) |
WO (2) | WO2001085199A1 (da) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1245216C (zh) * | 1999-10-04 | 2006-03-15 | 希龙公司 | 稳定化的含多肽的液体药物组合物 |
US6905683B2 (en) | 2000-05-03 | 2005-06-14 | Novo Nordisk Healthcare A/G | Human coagulation factor VII variants |
US7015194B2 (en) | 2000-05-10 | 2006-03-21 | Novo Nordisk A/S | Pharmaceutical composition comprising factor VIIa and anti-TFPI |
ES2429523T3 (es) | 2000-09-13 | 2013-11-15 | Novo Nordisk Health Care Ag | Variantes del factor VII de coagulación humana |
EP2226385B1 (en) * | 2000-09-13 | 2013-07-10 | Novo Nordisk Health Care AG | Human Coagulation Factor VII Variants |
WO2002036155A1 (en) * | 2000-11-03 | 2002-05-10 | Zymogenetics, Inc. | Use of blood coagulation factor xiii for treating haemophilia a |
WO2002038162A1 (en) | 2000-11-09 | 2002-05-16 | The Scripps Research Institute | MODIFIED FACTOR VIIa |
DE60129599T2 (de) * | 2000-11-10 | 2008-04-17 | Zymogenetics, Inc., Seattle | Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b |
AU2002229510A1 (en) * | 2001-02-05 | 2002-08-19 | Novo Nordisk Health Care Ag | Combined use of factor vii polypeptides and factor viii polypeptides |
US6979445B2 (en) * | 2001-02-21 | 2005-12-27 | Zymogenetics, Inc | Method for treating von willebrand's disease |
US7115559B2 (en) * | 2001-09-10 | 2006-10-03 | Zymogenetics Inc. | Method for treating coumarin-induced hemorrhage |
US7052868B2 (en) | 2001-09-27 | 2006-05-30 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
US6960657B2 (en) | 2001-11-02 | 2005-11-01 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
EP1446147A1 (en) * | 2001-11-09 | 2004-08-18 | Novo Nordisk Health Care AG | Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid |
US20030119723A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides |
US7291587B2 (en) | 2001-11-09 | 2007-11-06 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides |
EP1446148A1 (en) * | 2001-11-09 | 2004-08-18 | Novo Nordisk A/S | Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid |
CN101675991A (zh) * | 2001-12-21 | 2010-03-24 | 诺和诺德医疗保健公司 | 因子ⅶ多肽的液体组合物 |
ATE428439T1 (de) * | 2001-12-21 | 2009-05-15 | Novo Nordisk Healthcare Ag | Flüssige zusammensetzung aus faktor vii polypeptiden |
PT1517698E (pt) | 2002-06-21 | 2014-11-19 | Novo Nordisk Healthcare Ag | Composições sólidas estabilizadas de polipéptidos do fator viia |
US6911323B2 (en) | 2002-09-25 | 2005-06-28 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
EA008038B1 (ru) | 2003-01-08 | 2007-02-27 | Чирон Корпорейшн | Стабилизированные водные композиции, содержащие ингибитор пути метаболизма, тканевого фактора (tfpi) или вариант ингибитора пути метаболизма тканевого фактора |
WO2004112828A1 (en) | 2003-06-25 | 2004-12-29 | Novo Nordisk Health Care Ag | Liquid composition of factor vii polypeptides |
JP5653572B2 (ja) | 2003-08-14 | 2015-01-14 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 第vii因子ポリペプチドの液状水性医薬組成物 |
ES2381110T3 (es) | 2003-09-09 | 2012-05-23 | Novo Nordisk Health Care Ag | Polipéptidos de factor VII de coagulación |
WO2005107795A1 (en) * | 2004-05-11 | 2005-11-17 | Novo Nordisk Health Care Ag | Use of factor viia for the treatment of burn traumas |
WO2005115442A1 (en) * | 2004-05-25 | 2005-12-08 | Novo Nordisk Health Care Ag | Use of coagulation factor xiii for treatment of post surgical bleedings |
EP1784415A2 (en) * | 2004-08-27 | 2007-05-16 | Novo Nordisk Health Care AG | Purification of factor xiii polypeptides from biological materials |
WO2006026998A1 (en) * | 2004-09-10 | 2006-03-16 | Pharmaorigin Aps | Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
AU2005308830B2 (en) | 2004-11-23 | 2012-01-19 | Zymogenetics, Inc. | Purification of recombinant human factor XIII |
US20090130086A1 (en) * | 2005-02-28 | 2009-05-21 | Novo Nordisk Health Care Ag | FXIII Variants with Improved Properties |
EP1919499A2 (en) * | 2005-07-29 | 2008-05-14 | Universiteit van Maastricht | Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor |
WO2007104317A1 (en) * | 2006-03-16 | 2007-09-20 | Drugrecure Aps | Methods for local treatment with factor vii |
JP5122562B2 (ja) * | 2006-07-17 | 2013-01-16 | ノボ ノルディスク ヘルス ケア アーゲー | 増加した活性を有する第viia因子アナログの新規用途 |
US20100166729A9 (en) * | 2007-04-13 | 2010-07-01 | Madison Edwin L | Modified factor VII polypeptides and uses thereof |
TWI538916B (zh) | 2008-04-11 | 2016-06-21 | 介控生化科技公司 | 經修飾的因子vii多肽和其用途 |
EP2268267B1 (en) | 2008-04-21 | 2017-06-14 | Novo Nordisk Health Care AG | Dry transglutaminase composition |
EP2149603A1 (en) | 2008-07-28 | 2010-02-03 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Factor IX variants with clotting activity in absence of their cofactor and their use for treating bleeding disorders |
UA112050C2 (uk) * | 2008-08-04 | 2016-07-25 | БАЄР ХЕЛСКЕР ЛЛСі | Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi) |
KR101792032B1 (ko) | 2008-12-19 | 2017-11-02 | 백스터 인터내셔널 인코포레이티드 | Tfpi 억제제 및 사용 방법 |
AU2011227714B2 (en) | 2010-03-19 | 2014-09-04 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
BR112013002739A2 (pt) * | 2010-08-05 | 2019-09-24 | Council Scient Ind Res | constructos de proteínas de fusão que possuem propriedades trombolíticas e anticoagulantes |
CN109111505A (zh) | 2012-03-21 | 2019-01-01 | 百深有限责任公司 | Tfpi抑制剂及其使用方法 |
EP2881463A1 (en) | 2013-12-09 | 2015-06-10 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Factor IX variants with clotting activity in absence of their cofactor and/or with increased F.IX clotting activity and their use for treating bleeding disorders |
JP6559188B2 (ja) * | 2017-07-06 | 2019-08-14 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
JP2018038398A (ja) * | 2017-09-04 | 2018-03-15 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
JP2018108089A (ja) * | 2018-02-19 | 2018-07-12 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
JP7444059B2 (ja) * | 2018-07-25 | 2024-03-06 | ソニーグループ株式会社 | 血液凝固系解析装置 |
JP6848016B2 (ja) * | 2019-07-16 | 2021-03-24 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
CN114728044A (zh) | 2019-08-15 | 2022-07-08 | 介控生化科技公司 | 用于皮下施用和按需求治疗的经修饰的因子vii多肽 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4221780A (en) * | 1978-12-04 | 1980-09-09 | Cort Joseph H | Method for producing high potency factor VIII |
JPH0780783B2 (ja) * | 1985-11-26 | 1995-08-30 | ノボ ノルディスク アクティーゼルスカブ | 出血障害の治療のための第▲VII▼a因子を含有する治療組成物 |
US5622988A (en) * | 1990-06-15 | 1997-04-22 | Novo Nordisk A/S | Use of a low molecular weight metabolite from fungus for reducing prolonged coagulation time |
DK261490D0 (da) * | 1990-10-31 | 1990-10-31 | Novo Nordisk As | New pharmaceutical compound |
CA2121028A1 (en) * | 1991-10-11 | 1993-04-15 | Ulla K. E. Hedner | Hemostatic composition for local hemostasis |
AU3423493A (en) * | 1991-12-31 | 1993-07-28 | Zymogenetics Inc. | Methods and compositions for reducing blood loss |
AU4784693A (en) * | 1992-07-24 | 1994-02-14 | Oklahoma Medical Research Foundation | Blockade of protein c activation reduces microvascular surgical blood loss |
DE4429118C2 (de) * | 1994-08-17 | 1997-01-16 | Siemens Ag | Radarsensor |
WO1997029792A1 (en) * | 1996-02-20 | 1997-08-21 | Cohesion Corporation | Tissue sealant compositions and methods of use thereof |
AU7907398A (en) * | 1997-06-23 | 1999-01-04 | Novo Nordisk A/S | Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function |
CA2318434A1 (en) * | 1997-12-23 | 1999-07-01 | Nuvas Llc | Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
WO1999058699A2 (en) * | 1998-05-14 | 1999-11-18 | Battelle Memorial Institute | Transgenic plant-derived human blood coagulation factors |
EP1148427A1 (en) * | 2000-04-21 | 2001-10-24 | Koninklijke KPN N.V. | Method of and system for creating a button type bookmark in a web browser displaying a user-selected part of the corresponding data file |
US7015194B2 (en) * | 2000-05-10 | 2006-03-21 | Novo Nordisk A/S | Pharmaceutical composition comprising factor VIIa and anti-TFPI |
US6825323B2 (en) * | 2001-01-10 | 2004-11-30 | The United States Of America As Represented By The Secretary Of The Army | Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same |
US20030203845A1 (en) * | 2001-02-05 | 2003-10-30 | Knudsen Jens Bjerre | Combined use of factor VII polypeptides and factor IX polypeptides |
AU2002229510A1 (en) * | 2001-02-05 | 2002-08-19 | Novo Nordisk Health Care Ag | Combined use of factor vii polypeptides and factor viii polypeptides |
US20030119741A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and aprotinin polypeptides |
US20060025336A1 (en) * | 2001-07-16 | 2006-02-02 | Novo Nordisk A/S | Pharmaceutical compositions comprising combinations of factor VII polypeptides and aprotinin polypeptides |
US7419949B2 (en) * | 2001-07-16 | 2008-09-02 | Novo Noridsk Healthcare A/G | Single-dose administration of factor VIIa |
US20030040480A1 (en) * | 2001-07-20 | 2003-02-27 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
US7291587B2 (en) * | 2001-11-09 | 2007-11-06 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides |
US7078479B2 (en) * | 2001-11-09 | 2006-07-18 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides |
US20030119723A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides |
WO2003039585A1 (en) * | 2001-11-09 | 2003-05-15 | Novo Nordisk Health Care Ag | Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
EP1446148A1 (en) * | 2001-11-09 | 2004-08-18 | Novo Nordisk A/S | Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid |
US7125846B2 (en) * | 2001-11-09 | 2006-10-24 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides |
JP2005526004A (ja) * | 2001-11-09 | 2005-09-02 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 第vii因子ポリペプチドおよびトラネキサム酸を含む薬学的組成物 |
US20030119743A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors |
US20030124118A1 (en) * | 2001-11-27 | 2003-07-03 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and protein S inhibitors |
-
2001
- 2001-05-10 DE DE60115422T patent/DE60115422T2/de not_active Expired - Fee Related
- 2001-05-10 WO PCT/DK2001/000324 patent/WO2001085199A1/en active IP Right Grant
- 2001-05-10 DK DK01931458T patent/DK1282438T3/da active
- 2001-05-10 EP EP01931458A patent/EP1282438B1/en not_active Expired - Lifetime
- 2001-05-10 ES ES01931460T patent/ES2254414T3/es not_active Expired - Lifetime
- 2001-05-10 CZ CZ20023667A patent/CZ20023667A3/cs unknown
- 2001-05-10 CN CNB018093116A patent/CN1304049C/zh not_active Expired - Fee Related
- 2001-05-10 EP EP05007833A patent/EP1593389A1/en not_active Withdrawn
- 2001-05-10 EP EP01931460A patent/EP1282439B1/en not_active Expired - Lifetime
- 2001-05-10 HU HU0301868A patent/HUP0301868A3/hu unknown
- 2001-05-10 AT AT01931458T patent/ATE300953T1/de not_active IP Right Cessation
- 2001-05-10 AU AU5822801A patent/AU5822801A/xx active Pending
- 2001-05-10 IL IL15255401A patent/IL152554A0/xx unknown
- 2001-05-10 JP JP2001581851A patent/JP2004505016A/ja not_active Withdrawn
- 2001-05-10 WO PCT/DK2001/000322 patent/WO2001085198A1/en active IP Right Grant
- 2001-05-10 PL PL01365042A patent/PL365042A1/xx not_active Application Discontinuation
- 2001-05-10 AU AU2001258230A patent/AU2001258230A1/en not_active Abandoned
- 2001-05-10 AT AT01931460T patent/ATE311198T1/de not_active IP Right Cessation
- 2001-05-10 JP JP2001581852A patent/JP2003532684A/ja active Pending
- 2001-05-10 AU AU2001258228A patent/AU2001258228B2/en not_active Ceased
- 2001-05-10 ES ES01931458T patent/ES2247106T3/es not_active Expired - Lifetime
- 2001-05-10 BR BR0110659-7A patent/BR0110659A/pt not_active IP Right Cessation
- 2001-05-10 CA CA002406583A patent/CA2406583A1/en not_active Abandoned
- 2001-05-10 DE DE60112429T patent/DE60112429T2/de not_active Expired - Lifetime
-
2002
- 2002-10-15 US US10/271,278 patent/US20030092627A1/en not_active Abandoned
- 2002-11-08 NO NO20025355A patent/NO20025355L/no not_active Application Discontinuation
-
2006
- 2006-03-28 US US11/391,065 patent/US20060199766A1/en not_active Abandoned
-
2007
- 2007-05-30 US US11/755,298 patent/US20070280920A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL152554A0 (en) | PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII | |
HK1059215A1 (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome | |
DE60018100D1 (en) | Polymorphe form von atorvastatin-calcium | |
AU6751101A (en) | Topical agent for dermatological use | |
SE0102315D0 (sv) | Compounds | |
GB9907461D0 (en) | Neurite regeneration | |
AR032394A1 (es) | Una composicion oral. | |
HK1068106A1 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
EP1404281A4 (en) | TOPICAL USE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN AND / OR MUCOSAL LESIONS, USE OF COMPOSITIONS AND COMPOUNDS IN THE TREATMENT OF SKIN AND / OR MUCOUS DISEASES | |
MXPA03010683A (es) | Composicion que contiene un peptido y un pigmento y el uso del mismo para oscurecer la piel. | |
EP1037918A4 (en) | METHOD AND COMPOSITIONS FOR INCREASING THE EFFICIENCY OF VACCINALS USING CHEMOKINES | |
HUP0303936A2 (hu) | Készítmény és alkalmazása | |
WO2001022917A8 (en) | Effervescent compositions comprising nimesulide | |
IT1319685B1 (it) | Formulazioni alimentari ad elevato contenuto di calcio. | |
HUP0002154A3 (en) | Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression | |
GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
WO2001060344A3 (en) | Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections | |
AU2002237251A1 (en) | A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv | |
SI1313489T1 (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome | |
AUPR611201A0 (en) | A composition for use in prophylaxis and/or treatment | |
CA96622S (en) | Pouch, primarily containing cleaning composition(s), fabric care composition(s) or the like | |
GB0004648D0 (en) | Compositions and mixtures for the treatment of skin | |
MX9709941A (es) | Nueva composicion farmaceutica con efecto anestesico. | |
GB0100646D0 (en) | Compositions for therapy and prophylaxis |